日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Reinvigorating CD8(+) T cells through ADRB1 blockade using copper-propranolol nanoparticles for enhanced immune checkpoint blockade therapy

利用铜-普萘洛尔纳米颗粒阻断ADRB1,增强免疫检查点阻断疗法,从而激活CD8(+) T细胞

Weng, Binshu; Zhu, Nan; Li, Huirong; Ding, Lishan; Wu, Yutong; Chen, Ying; Xi, Yijie; Lin, Lifan; Chen, Jiawen; Xin, Le; Ye, Jinjun; Hu, Yanfeng; Li, Guoxin; Guo, Weihong

The role of thoracic radiotherapy in the setting of immunotherapy in polymetastatic esophageal squamous cell carcinoma: a multi-center cohort study

胸部放射治疗在多发性转移性食管鳞状细胞癌免疫治疗中的作用:一项多中心队列研究

Liu, Qi; Chen, Junqiang; Shen, Wenbin; Ye, Jinjun; Luo, Honglei; Zhang, Xizhi; Liu, Wenyang; Xu, Yujin; Zhang, Yingying; Liu, Anwen; Li, Xiaopeng; Ge, Hong; Wang, Qifeng; Luo, Hui; Zhao, Lina; Xie, Conghua; Lin, Qin; Xie, Congying; Wang, Luhua; Zhao, Kuaile

d-lactate drives lysine d-lactylation to regulate metabolism in Escherichia coli

d-乳酸驱动赖氨酸d-乳酰化,从而调节大肠杆菌的代谢。

Zhang, Jianji; Zang, Yong; Yu, Zhiqing; Zhao, Fei; Wu, Jingya; Wang, Yuhan; Wang, Aiyuan; Zhai, Guijin; Han, Yanpu; Chen, Chen; Ye, Jinjun; Dong, Hanyang; Zhang, Kai

Tripartite motif-containing protein 28 promotes drug resistance to bortezomib in gastric cancer through proteasome activity regulation.

含有三方基序的蛋白质 28 通过蛋白酶体活性调节促进胃癌对硼替佐米的耐药性。

Xin Le, Han Shuoyu, Wang Zixin, Yuan Xinyu, Ye Yiwei, Liu Jidong, Bao Xing, Ye Jinjun

Precision palliative care in advanced/recurrent esophageal cancer patients treated with anti-PD-1/PD-L1 immunotherapy (ESO-Shanghai 25): a randomized, phase III Trial

针对接受抗PD-1/PD-L1免疫疗法治疗的晚期/复发性食管癌患者的精准姑息治疗(ESO-上海25):一项随机、III期试验

Hao, Shengnan; Wang, Xiaomin; Ding, Huiping; Chen, Yun; Liu, Qi; Zhang, Junhua; Fan, Xingwen; Wu, Zhenhua; Lin, Ying; Xu, Xiaofang; Mao, Guangmin; Ai, Dashan; Deng, Jiaying; Zhu, Hongcheng; Ye, Jinjun; Mo, Miao; Hu, Zhihuang; Wang, Huijie; Cheng, Wenwu; Feng, Wei; Ling, Yiqun; Xu, Yufen; Du, Shisuo; Wang, Jialei; Zhao, Kuaile

Radiation Dose-Volume Effects on Negative Tumor-Draining Lymph Nodes Affected T-cell Activation and Prognosis in Esophageal Cancer with Chemoradiotherapy

放射剂量体积效应对阴性肿瘤引流淋巴结的影响,进而影响食管癌放化疗中T细胞活化和预后

Tseng, Ihsuan; Chen, Yun; Ai, Dashan; Zhu, Zhengfei; Zhao, Weixin; Fan, Min; Li, Ling; Zhu, Hongcheng; Li, Fangfang; Xu, Yang; Yu, Lu; Wang, Zezhou; Wang, Juanqi; Liu, Qi; Deng, Jiaying; Hao, Shengnan; Fan, Qingsong; Ye, Jinjun; Zhou, Jialiang; Wu, Chaoyang; Tang, Huarong; Lin, Qin; Li, Jiancheng; Li, Yunhai; Wei, Shihong; Luo, Hui; Cao, Jianzhong; Zheng, Xiangpeng; Huang, Guang; Zheng, Yuwei; Ping, Bo; Zhao, Kuaile

Comparative analysis of immunochemotherapy with versus without radiation therapy for stage IVB esophageal squamous cell carcinoma confined to non-regional nodal metastases: a multicenter propensity score matching study

免疫化疗联合或不联合放疗治疗IVB期食管鳞状细胞癌(局限于非区域淋巴结转移)的疗效比较分析:一项多中心倾向评分匹配研究

Liu, Qi; Chen, Junqiang; Xu, Yuanji; Shen, Wenbin; Ye, Jinjun; Luo, Honglei; Zhang, Xizhi; Liu, Wenyang; Xu, Yujin; Zhang, Yingying; Liu, Anwen; Li, Xiaopeng; Ge, Hong; Wang, Qifeng; Luo, Hui; Zhao, Lina; Xie, Conghua; Lin, Qin; Xie, Congying; Xiong, Jianping; Chen, Weiwei; Wang, Luhua; Zhao, Kuaile

Salvage involved-field versus extended-field chemoradiotherapy for postoperative lymph node metastasis in esophageal squamous cell carcinoma: a retrospective clinical study

食管鳞状细胞癌术后淋巴结转移的挽救性局部放化疗与扩大野放化疗的比较:一项回顾性临床研究

Liu, Wenqian; Ge, Dongfang; Wang, Tian; Zhao, Minghong; Wang, Shouhua; Wu, Daguang; Zhou, Xuefeng; Fan, Yuwei; Xia, Chunjun; Guo, Qing; Ren, Yuanyuan; Shan, Huiguo; Wang, Qiang; Shi, Yuxi; Zhou, Lei; Li, Hui; Guo, Yiyu; Fang, Ying; Gu, Dayong; Zhang, Zhi; Zhou, Guoren; Shi, Haifeng; Ye, Jinjun

ESO-Shanghai 20: phase III clinical trial of anti-PD-1 therapy with local intervention for oligometastatic ESCC

ESO-上海 20:抗 PD-1 疗法联合局部干预治疗寡转移性食管鳞状细胞癌的 III 期临床试验

Mao, Guangmin; Xin, Zhuocheng; Fan, Qingsong; Zhu, Huijuan; Ye, Jinjun; Zhou, Long; He, Yufeng; Xu, Benhua; Chen, Cheng; Li, Zhijun; Gu, Xiaowei; Li, Xianfeng; Wang, Xiaomin; Guo, Junjun; Xu, Zhengyang; Wan, Peng; Zhang, Yunxia; Zhang, Fuzheng; Huang, Canhong; Yi, Qiong; Huang, Jiangqiong; Liang, Shixiong; Chen, Junqiang; Lin, Yu; Fang, Qingliang; Chen, Yun; Ai, Dashan; Zhu, Hongcheng; Hao, Shengnan; Liu, Qi; Zhao, Kuaile

Effectiveness and safety of first-line pembrolizumab plus chemotherapy in patients with advanced/recurrent or metastatic esophageal squamous cell carcinoma in China: a real-world multicenter study

在中国,一线帕博利珠单抗联合化疗治疗晚期/复发或转移性食管鳞状细胞癌患者的有效性和安全性:一项真实世界多中心研究

Lin, Yu; Shen, Wenbin; Ye, Jinjun; Luo, Honglei; Zhang, Xizhi; Xu, Yuanji; Lin, Qin; Liu, Wenyang; Zhang, Yingying; Xu, Yujin; Jiang, Wei; Zhao, Lina; Liu, Anwen; Wu, Lei; Ge, Hong; Xie, Conghua; Zhao, Kuaile; Chen, Junqiang; Wang, Luhua; Liu, Qi